Intimation of closure of Trading window as per SEBI(PIT) Regulation 2015 for the quarter ended on 31st december 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare has informed the BSE that its trading window will remain closed from 1 January 2026 until 48 hours after the announcement of its unaudited financial results for the quarter and half-year ended 31 December 2025. The closure applies to all designated persons and their immediate relatives, in line with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The exact date of the board meeting to approve the Q3/H2 FY26 results will be communicated later. The intimation was signed by Umesh Kumar, Additional Director.
This is a routine, mandatory regulatory filing ahead of quarterly results. It restricts insiders from trading in the company's shares during the silent period but carries no material impact on the stock price or shareholder value.